Cary Street Partners Investment Advisory’s Idexx Laboratories IDXX Stock Holding History

Cary Street Partners Investment Advisory's IDXX Position: Q2 2026 in Review

Cary Street Partners Investment Advisory increased its Idexx Laboratories (IDXX) stake by 33% in Q2 2026, buying an estimated $43.2K and bringing the position to 307 shares worth $162K. The position accounts for 0.03% of the portfolio, ranked #422.

Cary Street Partners Investment Advisory first reported a position in IDXX in Q3 2020 and has held it in 13 quarters since. The position peaked at $255K in Q2 2023. 1,047 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

• Cary Street Partners Investment Advisory held 307 shares of Idexx Laboratories worth $162K as of Q2 2026.
• Cary Street Partners Investment Advisory bought 77 Idexx Laboratories shares in Q2 2026, an estimated $43.2K.
• Idexx Laboratories made up 0.03% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #422 holding.
• Cary Street Partners Investment Advisory first reported a position in Idexx Laboratories in Q3 2020 and has held it in 13 quarters since.
• Cary Street Partners Investment Advisory's Idexx Laboratories position peaked at $255K in Q2 2023.
• 1,047 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.